Provided by Tiger Trade Technology Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

2.13
-0.0600-2.74%
Post-market: 2.150.0200+0.94%16:30 EDT
Volume:30.09K
Turnover:64.24K
Market Cap:6.43M
PE:-0.25
High:2.23
Open:2.23
Low:2.10
Close:2.19
52wk High:24.90
52wk Low:1.52
Shares:3.02M
Float Shares:2.79M
Volume Ratio:0.38
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.4407
EPS(LYR):-20.0407
ROE:-307.69%
ROA:-76.20%
PB:1.17
PE(LYR):-0.11

Loading ...

Intelligent Bio Solutions Says Holders Exercise Prefunded Warrants for 285,000 Shares

Reuters
·
1 hour ago

Intelligent Bio Solutions Submits FDA 510(k) Filing for Fingerprint Drug Test System Seeking Codeine Clearance

Reuters
·
Sep 09

Intelligent Bio Solutions Reports 98.2% Accuracy in Clinical Study of Fingerprint Codeine Screening Device

Reuters
·
Sep 01

Intelligent Bio Solutions Prices USD 5 Million Private Placement at USD 2.46 Per Share Unit

Reuters
·
Sep 01

Intelligent Bio Solutions - Company Expects to Submit 510(k) Application in September 2026 for U.S. Market Entry

THOMSON REUTERS
·
Sep 01

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

THOMSON REUTERS
·
Sep 01

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Sep 01

Intelligent Bio Solutions Posts Investor Presentation on Fingerprint Sweat Drug Testing System

Reuters
·
Aug 28

Intelligent Bio Solutions FY26 Net Loss Widens to $12.47 Million; Revenue Rises 38% to $4.2 Million

Reuters
·
Aug 19

Press Release: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Dow Jones
·
Aug 19

Intelligent Bio Solutions completes fingerprint drug screening study

TIPRANKS
·
Aug 11

Intelligent Bio Solutions Completes Method Comparison Study for Fingerprint Drug Screening System Ahead of FDA 510(k) Filing

Reuters
·
Aug 11

Intelligent Bio Solutions Completes Usability Study for FDA Filing of Codeine Fingerprint Drug Test

Reuters
·
Aug 05

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

THOMSON REUTERS
·
Aug 05

Intelligent Bio Solutions Says Shares Outstanding Total 3,018,188 as of July 31, 2026

Reuters
·
Aug 04

Intelligent Bio Solutions Completes Interference Study for Fingerprint Codeine Screening System Ahead of FDA Filing

Reuters
·
Aug 03

Intelligent Bio Solutions Clears Cybersecurity, Software Review Items Ahead of FDA 510(k) Filing in H2 2026

Reuters
·
Jul 23

Intelligent Bio Solutions - on Track for 510(k) Submission in H2 2026

THOMSON REUTERS
·
Jul 23

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

THOMSON REUTERS
·
Jul 23

Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-billion-dollar U.S. Drug Screening Market

THOMSON REUTERS
·
Jul 21